PGT-A (Preimplantation Genetic Testing For Aneuploidy)
Don’t Risk your pregnancy success without choosing the right selection of chromosomally normal embryos.
Reprogene PGT-A test is the most comprehensive screening option that analyzes all 24 chromosomes for aneuploidy. We use the most recently developed technology, high-resolution Next Generation Sequencing (NGS), to directly “read” thousands of DNA sequences on each chromosome and this information is used during analysis with a sophisticated software program to determine the ploidy status of the embryo.
Reprogene PGT-A test have the lowest mosaicism rate in the field and allows the embryologist to attain information about the genetic background of the embryos before they transfer or freeze. With the results provided by PGT-A, you will have increased likelihood of implantation, reduced chance of miscarriage, and better odds of giving birth to a healthy baby by eliminate the possibility of chromosome aneuploidy.
Increase Chance of Implantation
Increase your IVF implantation rate regardless of maternal age by using comprehensive chromosome screening.
Low Risk of Miscarriage
Eliminate the possibility of chromosome aneuploidy by testing your embryo with PGT-A.
Save Time and Cost
Reduce time and costs of having a healthy baby by minimizing number of IVF cycles needed that allows for single embryo transfer.
Reduce Chance of Offspring With Aneuploidy
Better odds of giving birth to a healthy baby by eliminate the possibility of chromosome aneuploidy.